Last reviewed · How we verify
NCT07361445
Agilis RF TSP Early Feasibility Study
NA trial testing Transseptal procedure with Agilis RF TSP System. in Cardiac Arrythmias in 20 participants. Currently enrolling.
1 June 2026
Quick facts
| Lead sponsor | Abbott Medical Devices |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 16 February 2026 |
| Primary completion | 1 June 2026 |
| Estimated completion | 3 August 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Transseptal procedure with Agilis RF TSP System.
Conditions studied
- Cardiac Arrythmias — all drugs for Cardiac Arrythmias →
- Left Atrial Appendage Closure — all drugs for Left Atrial Appendage Closure →
Sponsor
Abbott Medical Devices — full company profile →
Who can join
18 and older, any sex, with Cardiac Arrythmias or Left Atrial Appendage Closure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a prospective, acute, first-in-human, early feasibility study intended to assess the initial safety and performance of the Agilis™ Radiofrequency (RF) Transseptal (TSP) System in crossing the atrial septum for left atrial and left ventricular access during cardiac electrophysiology (EP) and interventional cardiology (IC) procedures. This study will be conducted in an acute setting. Subjects will be followed through hospital discharge, and no follow-up visits will be required for this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07361445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrythmias
Currently open trials in the same condition.
- NCT03444259 — Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients · active not recruiting
Other Abbott Medical Devices trials
Trials by the same sponsor.
- NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
- NCT07509658 — TriClip Japan Post-Approval Study · recruiting
- NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
- NCT06676072 — A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07361445 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
- Last refreshed: 11 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07361445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing